Skip to main content
Xenocor, Mark Foster, Board Member

Mark Foster

Board Member

Mark Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies. Mr. Foster will provide strategic council to augment current fundraising, production, commercialization and distribution efforts at Xenocor.

He is currently the CEO of Trice Medical a venture-backed company that has a portfolio of products for minimally invasive diagnostic and therapeutic orthopedic procedures.  In his tenure at Trice, he has acquired and integrated two companies, raised over 60M of debt/equity, expanded the employee base from 12 to 100 and drove significant increase in asset value.

He has held senior management positions focused on business development to include fund-raising, licensing, M&A, commercialization and supply chain initiatives at two large, public companies, Smith and Nephew and Boston Scientific.